×

FDA To Delay Galvus?

5:05 AM ET Tue, 20 Feb 2007

Market sources tell CNBC Europe that the FDA may deal a blow to Novartis at the end of the month when it publishes findings on Galvus, Novartis' blockbuster pipeline diabetes drug. CNBC's Dan Scott reports from Zurich.